News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
JOHNSON JOHN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/20/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/08/2021 |
4/A
| JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 478,312 shares
@ $0
Granted 10,367 options to buy
@ $22.39, valued at
$232.1k
Granted 31,360 options to buy
@ $7.02, valued at
$220.1k
Granted 31,360 options to buy
@ $5.62, valued at
$176.2k
Granted 31,360 options to buy
@ $9.89, valued at
$310.2k
Granted 215,600 options to buy
@ $1.99, valued at
$429k
Granted 68,600 options to buy
@ $2.43, valued at
$166.7k
Granted 19,650 options to buy
@ $2.37, valued at
$46.6k
|
|
|
|